Older adults face unique barriers in hypertension management, including comorbidities, mobility limitations, and medication adherence challenges, impacting digital health tool effectiveness. Trials ...

Fingernails, often overlooked, are biological indicators of health. Conditions like clubbing, white flecks (leukonychia), ...

Researchers have a clearer picture on COVID-19 effects on the heart. Dr. Mike breaks down what you need to know to stay ...

New study reveals gum disease treatment can reduce cardiovascular risk by 10% annually, with intensive dental cleanings ...

People who have tried medication to lower their dangerously high levels of cholesterol and other blood fats – without success ...

“We’ve shown that lifelong blood pressure control is an investment in how well the heart ages. Our hearts remember decades of blood pressure exposure. Therefore, protecting heart health must start ...

Background: Cardiovascular disease (CVD) prevalence is rising among younger women in the US. Hypertensive disorders of pregnancy (HDP) are early indicators of cardiovascular risk, yet it remains ...

NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that ...

Rutgers researchers have discovered that a popular diabetes drug may reduce the health benefits people expect from it. A commonly prescribed medication for diabetes might actually be working against ...

Amgen's Repatha lowered first heart attacks and strokes by 36% in a major trial, suggesting PCSK9 drugs may prevent acute ...

Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.

In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...